Close
Skip to content

Epigenetics and Nanomedicine

The Epigenetics and Nanomedicine research group was established in 2015 as a result of the CINN’s growing activity in the biomedical field.

The current research lines are focused on six main areas:

  • Application of new technologies in the search for epigenetic biomarkers related to aging and human carcinogenesis that are useful in clinical practice.
  • Development of nanoparticles for the administration of combination of antitumor epigenetic drugs.
  • Identification of epigenetic changes in response to nanomaterials, particularly graphene and graphenic materials.
  • In-situ analysis of subcellular architecture.
  • New inorganic antimicrobial products.
  • Omics in health: Advanced techniques to study the bioactive role of food
  • Tissue engineering: Solutions against peri-implantitis, ceramic materials for long-lasting implants, bone substitutes.

Our researchers lead 4 research groups of the Health Research Institute of the Principality of Asturias  (ISPA):

nanomedicine